Science & Enterprise subscription

Follow us on Twitter

  • New post on Science and Enterprise: Taking a Break https://t.co/QgH851GMZX #Science #Business
    about 2 days ago
  • Total venture capital funding in the U.S. for first six months of 2019 reached levels not seen since the year 2000,… https://t.co/cGSC6j1Xl8
    about 2 days ago
  • New post on Science and Enterprise: Infographic – U.S. Venture Funds Near 20-Year Highs https://t.co/mIkraoGRAH #Science #Business
    about 2 days ago
  • A set of computational tools developed at Purdue University enables public safety agencies to monitor potentially c… https://t.co/NHSLm9YBBG
    about 3 days ago
  • New post on Science and Enterprise: A.I. Helps Visualize Emergency Social Media Data https://t.co/E94lXHnPsa #Science #Business
    about 3 days ago

Please share Science & Enterprise

Hearing Loss Cell Therapy Licensed in $625M Deal

Man with headphones

A biotechnology company developing regenerative treatments for various disorders is licensing its lead therapy candidate for hearing loss to Astellas Pharma. . . . → Read More: Hearing Loss Cell Therapy Licensed in $625M Deal

Trial to Test App Alerting for Dementia-Linked Drugs

Phone and keyboard

A mobile and computer app that alerts older citizens about a class of drugs associated with Alzheimer’s disease will soon be tested in a clinical trial. . . . → Read More: Trial to Test App Alerting for Dementia-Linked Drugs

Trial Shows Immunotherapies Extend Life with Melanoma

T-cell lymphocyte

First results from a clinical trial show a combination of immunotherapies extends survival among patients with melanoma, but shorter periods for other solid-tumor cancers. . . . → Read More: Trial Shows Immunotherapies Extend Life with Melanoma

Analysis – Most New Drugs Not Adding Patient Benefits

Tablet with charts

An analysis of drugs approved for use in Germany since 2011 shows no evidence most treatments provide new or added benefits to patients compared to standard care. . . . → Read More: Analysis – Most New Drugs Not Adding Patient Benefits

Voice Indicators to Monitor Dementia Progression

Brain circuits illustration

A company developing diagnostics for cognitive disorders from changes in speech patterns is partnering on vocal biomarkers to track progression of a form of dementia. . . . → Read More: Voice Indicators to Monitor Dementia Progression

Defense Dept Funding Fast TBI Diagnostics Kit

Road-side bomb

A medical device company in Finland is receiving a U.S. Department of Defense grant to develop a kit for soldiers in the field to quickly detect concussions. . . . → Read More: Defense Dept Funding Fast TBI Diagnostics Kit

Blockchain Added to Clinical Trials Management

Blockchain network graphic

A contract research organization, or CRO, specializing in clinical trials is adding blockchain capability for data management, with help from an engineering consulting firm. . . . → Read More: Blockchain Added to Clinical Trials Management

Start-Up Creating Blood Tests, Apps for Mental Disorders

Blood sample tubes

A new enterprise based on psychiatric and molecular research at Indiana University is developing precision-medicine diagnostics for pain and mental disease. . . . → Read More: Start-Up Creating Blood Tests, Apps for Mental Disorders

Trial Testing Paramedic-Delivered Stroke Drug

Ambulance

A clinical trial is getting underway testing a treatment for stroke delivered to patients by emergency medical technicians on the way to the hospital. . . . → Read More: Trial Testing Paramedic-Delivered Stroke Drug

Two Biotechs Each Issue $300M+ IPOs

NASDAQ share price display

Two biotechnology enterprises in the U.S. issued their initial public stock offerings yesterday, with each company raising at least $300 million in their transactions. . . . → Read More: Two Biotechs Each Issue $300M+ IPOs